within Pharmacolibrary.Drugs.ATC.C;

model C08CA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.11,
    Cl             = 0.014,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 15.0
  );

  annotation(Documentation(
    info ="<html><body><p>Nitrendipine is a dihydropyridine calcium channel blocker used primarily for the treatment of hypertension. It works by relaxing vascular smooth muscle, resulting in reduced peripheral resistance and blood pressure. Nitrendipine is approved for hypertension management in several countries, though its use has declined in some regions due to newer antihypertensive drugs.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from healthy adult volunteers (age 18-45), after a single oral 20 mg dose of nitrendipine under fasting conditions.</p><h4>References</h4><ol><li><p>Voruganti, S, et al., &amp; Yamsani, MR (2014). Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits. <i>European journal of drug metabolism and pharmacokinetics</i> 39(4) 277–281. DOI:<a href=&quot;https://doi.org/10.1007/s13318-013-0156-7&quot;>10.1007/s13318-013-0156-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24092617/&quot;>https://pubmed.ncbi.nlm.nih.gov/24092617</a></p></li><li><p>Soons, PA, &amp; Breimer, DD (1991). Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. <i>British journal of clinical pharmacology</i> 32(1) 11–16. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1991.tb05606.x&quot;>10.1111/j.1365-2125.1991.tb05606.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1888628/&quot;>https://pubmed.ncbi.nlm.nih.gov/1888628</a></p></li><li><p>Soons, PA, et al., &amp; Breimer, DD (1993). Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics. <i>European journal of clinical pharmacology</i> 44(2) 163–169. DOI:<a href=&quot;https://doi.org/10.1007/BF00315475&quot;>10.1007/BF00315475</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8453961/&quot;>https://pubmed.ncbi.nlm.nih.gov/8453961</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C08CA08;
